Boyapati Venkaiah

437 total citations
9 papers, 276 citations indexed

About

Boyapati Venkaiah is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Boyapati Venkaiah has authored 9 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Boyapati Venkaiah's work include Protease and Inhibitor Mechanisms (7 papers), Peptidase Inhibition and Analysis (5 papers) and Signaling Pathways in Disease (3 papers). Boyapati Venkaiah is often cited by papers focused on Protease and Inhibitor Mechanisms (7 papers), Peptidase Inhibition and Analysis (5 papers) and Signaling Pathways in Disease (3 papers). Boyapati Venkaiah collaborates with scholars based in United States, Norway and Japan. Boyapati Venkaiah's co-authors include Raymond Sawaya, Jasti S. Rao, Shravan K. Chintala, Yoshinori Go, Sanjeeva Mohanam, Ziya L. Gokaslan, Garth L. Nicolson, Juàn Fueyo, Candelaria Gomez‐Manzano and Kazunari Oka and has published in prestigious journals such as Oncogene, Biochemical and Biophysical Research Communications and International Journal of Oncology.

In The Last Decade

Boyapati Venkaiah

9 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boyapati Venkaiah United States 7 138 134 123 44 32 9 276
Aasmund Berner Norway 7 127 0.9× 138 1.0× 171 1.4× 54 1.2× 38 1.2× 7 354
Mahdhia Soula-Rothhut France 8 262 1.9× 121 0.9× 98 0.8× 58 1.3× 17 0.5× 9 406
Scott Chartrand United States 5 236 1.7× 126 0.9× 93 0.8× 22 0.5× 28 0.9× 5 368
M. Denijn Netherlands 7 179 1.3× 120 0.9× 117 1.0× 97 2.2× 22 0.7× 10 376
Douglas Boyd United States 8 198 1.4× 209 1.6× 191 1.6× 80 1.8× 12 0.4× 11 416
Ran Afik Israel 6 142 1.0× 70 0.5× 201 1.6× 42 1.0× 18 0.6× 9 451
Marja‐Riitta Väisänen Finland 11 169 1.2× 84 0.6× 97 0.8× 76 1.7× 19 0.6× 12 392
K Shiiba Japan 10 259 1.9× 74 0.6× 193 1.6× 26 0.6× 24 0.8× 18 468
Lisa J. Guerrero United States 10 154 1.1× 99 0.7× 102 0.8× 15 0.3× 25 0.8× 11 370
Susanna Teppo Finland 11 237 1.7× 139 1.0× 118 1.0× 43 1.0× 19 0.6× 16 419

Countries citing papers authored by Boyapati Venkaiah

Since Specialization
Citations

This map shows the geographic impact of Boyapati Venkaiah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boyapati Venkaiah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boyapati Venkaiah more than expected).

Fields of papers citing papers by Boyapati Venkaiah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boyapati Venkaiah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boyapati Venkaiah. The network helps show where Boyapati Venkaiah may publish in the future.

Co-authorship network of co-authors of Boyapati Venkaiah

This figure shows the co-authorship network connecting the top 25 collaborators of Boyapati Venkaiah. A scholar is included among the top collaborators of Boyapati Venkaiah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boyapati Venkaiah. Boyapati Venkaiah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Mohanam, Sanjeeva, Raymond Sawaya, Boyapati Venkaiah, et al.. (1999). Elevated levels of urokinase-type plasminogen activator and its receptor during tumor growth in vivo.. International Journal of Oncology. 14(1). 169–74. 16 indexed citations
2.
Gokaslan, Ziya L., Shravan K. Chintala, Julie E. York, et al.. (1998). Expression and role of matrix metalloproteinases MMP-2 and MMP-9 in human spinal column tumors. Clinical & Experimental Metastasis. 16(8). 721–728. 30 indexed citations
3.
Sawaya, Raymond, Yoshinori Go, Joon H. Uhm, et al.. (1998). Elevated Levels of Mr92,000 Type IV Collagenase during Tumor Growthin Vivo. Biochemical and Biophysical Research Communications. 251(2). 632–636. 43 indexed citations
4.
Chintala, Shravan K., Julie E. York, Boyapati Venkaiah, et al.. (1998). Expression and localization of urokinase-type plasminogen activator in human spinal column tumors. Clinical & Experimental Metastasis. 16(8). 713–719. 4 indexed citations
5.
Go, Yoshinori, Shravan K. Chintala, Francis Ali‐Osman, et al.. (1997). Cisplatin but not BCNU inhibits urokinase-type plasminogen activator levels in human glioblastoma cell lines in vitro. Clinical & Experimental Metastasis. 15(4). 447–452. 1 indexed citations
6.
Chintala, Shravan K., Francis Ali‐Osman, Yoshinori Go, et al.. (1997). Effect of cisplatin and BCNU on MMP-2 levels in human glioblastoma cell lines in vitro. Clinical & Experimental Metastasis. 15(4). 361–367. 20 indexed citations
7.
Chintala, Shravan K., Sanjeeva Mohanam, Yoshinori Go, et al.. (1997). Altered in vitro spreading and cytoskeletal organization in human glioma cells by downregulation of urokinase receptor. Molecular Carcinogenesis. 20(4). 355–365. 21 indexed citations
8.
Chintala, Shravan K., Juàn Fueyo, Candelaria Gomez‐Manzano, et al.. (1997). Adenovirus-mediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro. Oncogene. 15(17). 2049–2057. 82 indexed citations
9.
Go, Yoshinori, Shravan K. Chintala, Sanjeeva Mohanam, et al.. (1997). Inhibition of in vivo tumorigenicity and invasiveness of a human glioblastoma cell line transfected with antisense uPAR vectors. Clinical & Experimental Metastasis. 15(4). 440–446. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026